Search results for: 'nanoparticles pharma'

This research service provides an overview of the pharma-biotech industry in terms of critical success factors and alliance management.

This deliverable provides insights on the many macro issues facing the pharma and biotech industry. The industry is currently in a state of transition and is faced with a myraid of challenges including the dreaded patent cliff. This research service presents a total market forecast, market share analysis by leading companies, top therapeutic class...

The research service primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study provides key insights into the transforming pharmaceutical value chain, with the adoption of technology and shift towards digitalization of key processes ac...

This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...

This issue of the Nanotechnology Opportunity Engine profiles significant advancements in nanotechnology for various enhanced industrial applications. The featured innovations include Precision Vacuum-based Nanoparticle Deposition Systems, Carbon Nanotube Hybrid Material Platforms with Improved Performance, Roll-to-Roll UV Nanoimprint Lithography Sy...

With an inclination toward patient-centric care delivery, the pharma industry follows a robust, step-by-step approach to market commercialization, with a clear understanding of the market stakeholders, segments, and post-launch forecasts to create seamless go-to-market strategies, develop a positive image, and instill confidence among healthcare pr...

Microbiome science has become a key area of research for biopharmaceutical companies. At present, there are multiple start-ups emerging, which are focusing their resources towards the development of novel therapeutics as well as diagnostic/screening technologies and services. In an era of personalized medicine, the current trajectory of growth witn...

Nanoencapsulation embeds nanoparticles of solid, liquid, or gas, which are known as actives into a secondary shell material. The shell and core, also known as a nanoencapsulated system, is targeted to be delivered at a specific region to offer controlled release of the active in achieving specific end applications. Nanoencapsulation has been consid...